According to a new study published 3 days ago, researchers demonstrated that a single course of antibiotics was strong enough to alter the gastrointestinal microbiome for up to one year.
Antibiotics successfully fight infectious diseases and significantly reduce illness and death. There is definitely a time and place for these medications. However, many doctors still commonly over prescribe antibiotics.
In the US, antibiotic-resistant bacteria cause at least 2 million cases of disease and 23,000 fatalities annually.
In this study, the microbial diversity was severely affected for months after exposure in the healthy adults prescribed different antibiotics. Researchers specifically saw a decline in the abundance of butyrate producing bacteria.
The microbial diversity in the stool was significantly reduced for up to 4 months in participants taking clindamycin and up to 12 months in those taking ciprofloxacin. Amoxicillin had no significant effect on microbiome diversity, however, it was associated with the greatest number of antibiotic-resistant genes.
If a patient is prescribed a course of antibiotics, it is crucial he or she concurrently take Saccharomyces boulardii. This non-pathogenic yeast that protects the microbiome during antibiotic therapy. S. boulardii is one of my favorite gastrointestinal support products as it is protective to the intestinal epithelial cells and maintaining intestinal barrier function. It also increases SIgA secretion, directly inhibits colonization of harmful bacteria, and restores normal intestinal function in patients with diarrhea.
With the growing levels of antibiotic resistance and exit of major pharmaceutical companies from antibiotic development really makes phage therapy another great treatment option for the growing number of untreatable infections. They have a 80 to 90 percent success rate against bacteria likely to show antibiotic resistance, such as Escherichia coli.
In addition, there are many botanical extracts, essential oils, and silver that have a long history of antimicrobial properties while being relatively sparing to the beneficial bacteria that should be considered.
By Michael Jurgelewicz, DC, DACBN, DCBCN
Sharing is caring!
New study investigates vitamin D levels with lipid profiles in osteoporosis
Osteoporosis is a silent chronic disease associated with weakened bone mass and an increased risk of fracture. Vitamin…
New study shows prediabetes is ignored by primary care physicians
According to a study published 3 days ago in the Journal of the American Board of Family Medicine, less than 25% of…
New study demonstrates omega-3 fatty acids increase blood flow to regions of the brain associated with cognition
According to a new study published last Thursday in the Journal of Alzheimer's Disease, researchers showed…
Study recommends statin use for the primary prevention of cardiovascular disease
According to a new study published 3 days ago in JAMA, the U.S. Preventive Services Task Force (USPSTF) recommended the…
Glutamine and whey protein improve intestinal permeability in patients with Crohn’s Disease
Crohn's disease is a chronic illness where part of the digestive tract becomes inflamed and ulcerated marked with…
New review demonstrates the efficacy of probiotics in multiple sclerosis
Multiple sclerosis (MS) is a debilitating inflammatory, demyelinating, and autoimmune disease of the central…
New study demonstrates fish oils improve heart function post heart attack
According to a new study just published 3 days ago in journal Circulation, high dose fish oil post heart attack…
New Review Investigates the Efficacy of an IBS Diet in the Treatment of SIBO
Irritable bowel syndrome (IBS) can be debilitating causing cramping, abdominal pain, bloating, gas, diarrhea and…
New review of melatonin supplementation and depression
Depression is a major cause of disease burden worldwide which affects approximately 350 million people. Although…